BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17225086)

  • 1. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
    Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
    Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of feline calicivirus (FCV) from vaccinated cats and phylogenetic analysis of its capsid genes.
    Ohe K; Sakai S; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Soma T; Ishikawa Y; Taneno A
    Vet Res Commun; 2006 Apr; 30(3):293-305. PubMed ID: 16437305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
    Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
    J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
    Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
    Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S; Lowery D; Floyd-Hawkins K; King V
    Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.
    Smith SL; Afonso MM; Pinchbeck GL; Gaskell RM; Dawson S; Radford AD
    J Feline Med Surg; 2020 Jun; 22(6):602-607. PubMed ID: 31411533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.
    Ohe K; Takahashi T; Hara D; Hara M
    Vet Res Commun; 2008 Feb; 32(2):145-58. PubMed ID: 17899424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phylogenetic analyses of capsid protein gene in feline calicivirus isolates from Rio Grande do Sul in southern Brazil.
    Henzel A; Sá e Silva M; Luo S; Lovato LT; Weiblen R
    Virus Res; 2012 Feb; 163(2):667-71. PubMed ID: 22197423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline calicivirus strains isolated in Italy.
    Rinaldo D; Foti M; Bottari T; Fisichella V; Buonavoglia D
    Pol J Vet Sci; 2008; 11(4):359-61. PubMed ID: 19227135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
    Hohdatsu T; Sato K; Tajima T; Koyama H
    J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
    Huang C; Hess J; Gill M; Hustead D
    J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic analysis of field isolates of feline calcivirus (FCV) in Japan by sequencing part of its capsid gene.
    Sato Y; Ohe K; Murakami M; Fukuyama M; Furuhata K; Kishikawa S; Suzuki Y; Kiuchi A; Hara M; Ishikawa Y; Taneno A
    Vet Res Commun; 2002 Apr; 26(3):205-19. PubMed ID: 12090292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination.
    Pedersen NC; Hawkins KF
    Vet Microbiol; 1995 Nov; 47(1-2):141-56. PubMed ID: 8604546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of a calicivirus isolated from cats dying in an agitated state.
    Sato Y; Ohe K; Fukuyama M; Furuhata K; Kishikawa S; Sakai S; Kiuchi A; Hara M; Watanabe T; Ishikawa Y; Taneno A
    Vet Rec; 2004 Dec 18-25; 155(25):800-5. PubMed ID: 15651548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
    Poulet H; Brunet S; Leroy V; Chappuis G
    Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and genetic characterization of feline caliciviruses used in the development of a new trivalent inactivated vaccine in Japan.
    Masubuchi K; Wakatsuki A; Iwamoto K; Takahashi T; Kokubu T; Shimizu M
    J Vet Med Sci; 2010 Sep; 72(9):1189-94. PubMed ID: 20453450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures.
    Radford AD; Bennett M; McArdle F; Dawson S; Turner PC; Glenn MA; Gaskell RM
    Vaccine; 1997; 15(12-13):1451-8. PubMed ID: 9302760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.
    Spiri AM; Riond B; Stirn M; Novacco M; Meli ML; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.
    Wensman JJ; Samman A; Lindhe A; Thibault JC; Berndtsson LT; Hosie MJ
    Acta Vet Scand; 2015 Dec; 57():86. PubMed ID: 26655039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
    Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
    J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.